Page 56 - Read Online

Page 22 of 30 Raffetto et al. Vessel Plus 2021;5:36 https://dx.doi.org/10.20517/2574-1209.2021.16

REFERENCES
1. MacColl E, Khalil RA. Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease.
J Pharmacol Exp Ther 2015;355:410-28. DOI PubMed PMC
2. Sansilvestri-Morel P, Fioretti F, Rupin A, et al. Comparison of extracellular matrix in skin and saphenous veins from patients with
varicose veins: does the skin reflect venous matrix changes? Clin Sci (Lond) 2007;112:229-39. DOI PubMed
3. Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 2017;147:1-
73. DOI PubMed PMC
4. Kucukguven A, Khalil RA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr
Drug Targets 2013;14:287-324. PubMed PMC
5. Chen Y, Peng W, Raffetto JD, Khalil RA. Matrix metalloproteinases in remodeling of lower extremity veins and chronic venous
disease. Prog Mol Biol Transl Sci 2017;147:267-99. DOI PubMed PMC
6. Raffetto JD, Calanni F, Mattana P, Khalil RA. Sulodexide promotes venous contraction in rat inferior vena cava. J Vasc Surg Venous
Lymphat Disord 2017;5:145. DOI
7. Raffetto JD, Yu W, Wang X, Calanni F, Mattana P, Khalil RA. Sulodexide improves contraction and decreases matrix
metalloproteinase-2 and -9 in veins under prolonged stretch. J Cardiovasc Pharmacol 2020;75:211-21. DOI PubMed PMC
8. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J
Vasc Surg 2004;40:1248-52. DOI PubMed
9. Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg
Venous Lymphat Disord 2020;8:342-52. DOI PubMed
10. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann
Epidemiol 2005;15:175-84. DOI PubMed
11. Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology 2008;23:85-98.
DOI PubMed
12. Zsoter T, Cronin RF. Venous distensibility in patients with varicose veins. Can Med Assoc J 1966;94:1293-7. PubMed PMC
13. Naoum JJ, Hunter GC, Woodside KJ, Chen C. Current advances in the pathogenesis of varicose veins. J Surg Res 2007;141:311-6.
DOI PubMed
14. Mannello F, Medda V, Ligi D, Raffetto JD. Glycosaminoglycan sulodexide inhibition of MMP-9 gelatinase secretion and activity:
possible pharmacological role against collagen degradation in vascular chronic diseases. Curr Vasc Pharmacol 2013;11:354-65. DOI
PubMed
15. Naik B, Kumar M, Khanna AK, Suman PK. Clinico-histopathological study of varicose vein and role of matrix metalloproteinases-1,
matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinase-1 in varicose vein formation. Indian J Pathol Microbiol
2016;59:25-30. DOI PubMed
16. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic
activity of primary varicose veins. J Vasc Surg 1993;18:814-20. PubMed
17. Haviarova Z, Weismann P, Stvrtinova V, Benuska J. The determination of the collagen and elastin amount in the human varicose vein
by the computer morphometric method. Gen Physiol Biophys 1999;18 Suppl 1:30-3. PubMed
18. Kockx MM, Knaapen MW, Bortier HE, Cromheeke KM, Boutherin-Falson O, Finet M. Vascular remodeling in varicose veins.
Angiology 1998;49:871-7. DOI PubMed
19. Sansilvestri-Morel P, Rupin A, Jullien ND, et al. Decreased production of collagen Type III in cultured smooth muscle cells from
varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res 2005;42:388-98. DOI PubMed
20. Venturi M, Bonavina L, Annoni F, et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res
1996;60:245-8. DOI PubMed
21. Corcos L, De Anna D, Dini M, Macchi C, Ferrari PA, Dini S. Proximal long saphenous vein valves in primary venous insufficiency.
J Mal Vasc 2000;25:27-36. PubMed
22. Psaila JV, Melhuish J. Viscoelastic properties and collagen content of the long saphenous vein in normal and varicose veins. Br J
Surg 1989;76:37-40. DOI PubMed
23. Ono T, Bergan JJ, Schmid-Schonbein GW, Takase S. Monocyte infiltration into venous valves. J Vasc Surg 1998;27:158-66. DOI
PubMed
24. Raffetto JD, Qiao X, Beauregard KG, Khalil RA. Estrogen receptor-mediated enhancement of venous relaxation in female rat:
implications in sex-related differences in varicose veins. J Vasc Surg 2010;51:972-81. DOI PubMed PMC
25. Mekky S, Schilling RS, Walford J. Varicose veins in women cotton workers. An epidemiological study in England and Egypt. Br
Med J 1969;2:591-5. DOI PubMed PMC
26. Seidell JC, Bakx KC, Deurenberg P, van den Hoogen HJ, Hautvast JG, Stijnen T. Overweight and chronic illness--a retrospective
cohort study, with a follow-up of 6-17 years, in men and women of initially 20-50 years of age. J Chronic Dis 1986;39:585-93. DOI
PubMed
27. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone
concentrations in postmenopausal women. Int J Epidemiol 1991;20:151-6. DOI PubMed
28. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev
2000;21:514-50. DOI PubMed
29. Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 2001;97:669-72. DOI PubMed